[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369184-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369184-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hpv-and-p53-status-as-precision-determinants-of-head-and-neck-cancer-response-to-dna-pkcs-inhibition","HPV and p53 Status as Precision Determinants of Head and Neck Cancer Response to DNA-PKcs Inhibition","","Head and neck squamous cell carcinoma (HNSCC) treatment response is shaped by HPV and p53 genetics. HPV E6 promotes p53 degradation, while HPV-negative tumors often carry TP53 mutations. The study evaluates how ionizing irradiation (IR), the DNA-PKcs inhibitor peposertib, and their combination affect diverse HNSCC models in vitro and in vivo. Combined IR and peposertib reduces viability and delays DNA repair in multiple cell lines, yet the ultimate fate depends on p53/HPV status: p53-deficient cells undergo G2/M arrest and apoptosis, while p53-proficient lines preferentially senesce, with stronger durable responses in HPV+ xenografts.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hpv-and-p53-status-as-precision-determinants-of-head-and-neck-cancer-response-to-dna-pkcs-inhibition/369184/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hpv-and-p53-status-as-precision-determinants-of-head-and-neck-cancer-response-to-dna-pkcs-inhibition/369184.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-21","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do HPV status and p53 status influence treatment outcomes in HNSCC?","Question",{"text":63,"@type":64},"HPV-positive cancers degrade p53 through HPV E6, whereas HPV-negative cancers more frequently have TP53 mutations. The study shows that the combined treatment response ultimately depends on cellular p53 and/or HPV status.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does DNA-PKcs inhibition with peposertib play when combined with irradiation?",{"text":68,"@type":64},"Peoposertib inhibits DNA-PKcs, a key regulator of nonhomologous end joining (NHEJ). In combination with irradiation, it increases antitumor effectiveness by reducing viability, limiting proliferation, and causing DNA repair delay.",{"name":70,"@type":61,"acceptedAnswer":71},"What cellular fates are observed after combined IR and peposertib treatment?",{"text":72,"@type":64},"Cells lacking functional p53 arrest in G2/M and are eliminated by apoptosis, while p53-proficient models preferentially undergo senescence. In vivo, HPV+ xenografts show stronger and more durable responses.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369184,1790434244,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","HPV and p53 Status as Precision Determinants of Head and Neck Cancer Response to DNA-PKcs Inhibition in Combination with Irradiation  \nLiana Hayrapetyan1,2,3, Selina M. Roth1,2,3, Aurlie Quintin1,2, Lusine Hovhannisyan1,2,3, Mat Medo1,2, Rahel Riedo1,2, Julien G. Ott1, Joachim Albers4, Daniel M. Aebersold1, Yitzhak Zimmer1,2,†, and Michaela Medov1,2  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Major risk factors of head and neck squamous cell carcinoma (HNSCC) are tobacco use and human papillomavirus (HPV) . HPV E6 oncoprotein leads to p53 degradation, whereas HPVnegative cancers are frequently associated with TP53 mutations. Peposertib is a potent and selective, orally administered smallmolecule inhibitor of the catalytic subunit of the DNA-dependent kinase (DNA-PKcs), a key regulator of nonhomologous end joining (NHEJ) . NHEJ inhibition along with irradiation (IR)-induced DNA double-strand breaks has the potential to increase antitumor treatment efficacy. In this study, we investigated the responses of a panel of HNSCC models with distinct HPV and p53 status to treatments with IR, DNA-PKcs inhibition, and their combination in vitro and in vivo. IR-induced DNA damage combined with peposertib administration shortly before IR\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | results in decreased cell viability and proliferation and causes DNA repair delay in all studied HNSCC cell lines. However, our data confirm that the actual cell fate upon this treatment is determined by cellular p53 and/or HPV status. Cells lacking functional p53 due to its degradation by HPV or due to a loss-offunction mutation are arrested in the G2/M phase of the cell cycle and eliminated by apoptosis, whereas p53-proficient HNSCC cell lines preferentially undergo senescence. This is also recapitulated in vivo, where HPV+ UD-SCC-2 xenografts display stronger and more durable responses to the combined treatment as compared with p53 wild-type UM-SCC-74A tumors. In conclusion, DNAPKcs inhibitor peposertib should be further studied as a potential radiosensitizer for HNSCCs, taking into consideration the genetic background and the HPV status of a particular tumor. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nHead and neck squamous cell carcinomas (HNSCC) are among the most frequently diagnosed tumors worldwide, with mortality exceeding 500,000 deaths yearly (1). Major risk factors leading to the development of this malignancy include various environmental substances and pollutants (e.g., tobacco use, excessive alcohol consumption, etc.) as well as chronic infection with cancerogenic strains of human papillomavirus (HPV) and Epstein–Barr virus (2) . Whereas HPV-positive (HPV+) HNSCCs have favorable prognoses and good treatment response rates, continuous exposure to tobacco smoke worsens the burden of mutations and leads to poorer  \n1Department of Radiation Oncology, Inselspital Bern Un","cbCaifRs7iGA7i3g","https://ap.wps.com/l/cbCaifRs7iGA7i3g","pdf",27635981,16,"English","# Introduction\n## Background on HNSCC risk factors and HPV/p53 biology\n## Current treatment modalities and rationale for radiosensitizers","[{\"question\":\"How do HPV status and p53 status influence treatment outcomes in HNSCC?\",\"answer\":\"HPV-positive cancers degrade p53 through HPV E6, whereas HPV-negative cancers more frequently have TP53 mutations. The study shows that the combined treatment response ultimately depends on cellular p53 and/or HPV status.\"},{\"question\":\"What role does DNA-PKcs inhibition with peposertib play when combined with irradiation?\",\"answer\":\"Peoposertib inhibits DNA-PKcs, a key regulator of nonhomologous end joining (NHEJ). In combination with irradiation, it increases antitumor effectiveness by reducing viability, limiting proliferation, and causing DNA repair delay.\"},{\"question\":\"What cellular fates are observed after combined IR and peposertib treatment?\",\"answer\":\"Cells lacking functional p53 arrest in G2/M and are eliminated by apoptosis, while p53-proficient models preferentially undergo senescence. In vivo, HPV+ xenografts show stronger and more durable responses.\"}]","HPV and p53 Status as Precision Determinants of Head and Neck Cancer Response to DNA-PKcs Inhibition | PDF",1790181258,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1099eaf661b8f34b52677334e58f2c8.webp",983,1315,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62538570f4712a05ce30b6756346a8f0.webp",982,1314,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c89a8b33747320ac12e70e8de10f2cc.webp",981,1312,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/381482395b93bf4c8b437d6922a6b4a9.webp",980,1311]